Koninklijke DSM NV's ticker is and the CUSIP is N5017D122. A total of 1 filers reported holding Koninklijke DSM NV in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,697 | -6.0% | 1,409 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $170,949 | +0.8% | 1,409 | -1.9% | 0.00% | 0.0% |
Q1 2023 | $169,658 | -17.3% | 1,436 | -14.3% | 0.00% | -50.0% |
Q4 2022 | $205,065 | +13.3% | 1,675 | +6.2% | 0.00% | +100.0% |
Q3 2022 | $181,000 | -35.8% | 1,577 | -5.7% | 0.00% | -50.0% |
Q2 2022 | $282,000 | -6.6% | 1,673 | -0.4% | 0.00% | +100.0% |
Q1 2022 | $302,000 | -38.9% | 1,679 | -23.4% | 0.00% | 0.0% |
Q4 2021 | $494,000 | -11.3% | 2,191 | -21.4% | 0.00% | 0.0% |
Q3 2021 | $557,000 | -20.9% | 2,789 | -26.1% | 0.00% | 0.0% |
Q2 2021 | $704,000 | +14.5% | 3,775 | +4.1% | 0.00% | 0.0% |
Q1 2021 | $615,000 | +324.1% | 3,625 | +330.0% | 0.00% | – |
Q4 2020 | $145,000 | +110.1% | 843 | +102.2% | 0.00% | – |
Q3 2020 | $69,000 | +53.3% | 417 | +29.1% | 0.00% | – |
Q2 2020 | $45,000 | +21.6% | 323 | -1.8% | 0.00% | -100.0% |
Q1 2020 | $37,000 | -15.9% | 329 | -2.7% | 0.00% | 0.0% |
Q4 2019 | $44,000 | -2.2% | 338 | -9.4% | 0.00% | 0.0% |
Q3 2019 | $45,000 | -21.1% | 373 | -28.4% | 0.00% | -50.0% |
Q1 2019 | $57,000 | +11.8% | 521 | -16.0% | 0.00% | 0.0% |
Q4 2018 | $51,000 | -20.3% | 620 | +2.3% | 0.00% | 0.0% |
Q3 2018 | $64,000 | +6.7% | 606 | +1.2% | 0.00% | 0.0% |
Q2 2018 | $60,000 | -34.1% | 599 | -35.0% | 0.00% | -60.0% |
Q1 2018 | $91,000 | +8.3% | 921 | +4.5% | 0.01% | -28.6% |
Q4 2017 | $84,000 | – | 881 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRADLEY FOSTER & SARGENT INC/CT | 26,572 | $4,571,000 | 0.12% |
ARK Investment Management | 843 | $145,000 | 0.00% |